Skip to content

Cencora COR Animal Health — Revenue

Other product segments

Alliance Healthcare
$6.52B+12.9%
Other Healthcare Solutions
$1.05B+13.5%
Other non-strategic businesses
$619.78M+4.5%

Similar metrics at other companies

Phibro Animal Health logo
PAHCAnimal Health — Revenue
$291.23M+12.7%
Phibro Animal Health logo
PAHCAnimal Health — Revenue
$291.23M+12.7%
Elanco Animal Health Inc. logo
ELANPet Health — Revenue
$710M+11.8%
Elanco Animal Health Inc. logo
ELANFarm Animal: — Revenue
$642M+17.6%
Zoetis logo
ZTSLivestock — Revenue
$720M+14.8%
Zoetis logo
ZTSOther Non Pharmaceuticals — Revenue
$66M-7.0%

Other financials

Income statement

See full
Revenue$78.4B+3.8%
Gross profit$3.6B+17.3%
Operating income$1.1B+10.3%
Net income$1.6B+129%
EPS (diluted)$8.40+128%

Balance sheet

See full
Cash & equivalents$2.2B+10.0%
Total debt$12.2B+71.9%
Total equity$3.4B+235%
Total assets$81.7B+14.7%

Cash flow

See full
Operating cash flow-$2.3B+15.2%
CapEx$165.6M+28.3%
Free cash flow-$2.4B+14.2%

Valuation

See full
Market cap$55.83B-1.9%
Enterprise value$65.84B+6.1%
P/E15.5×+3.1×
P/S0.2×0.0×

Profitability

See full
Gross margin3.8%+0.4pp
Operating margin0.8%0.0pp
Net margin0.6%-0.1pp
FCF margin1.1%+1.0pp

Returns & leverage

See full
Return on equity130.6%-99.8pp
Debt / equity3.6×-3.4×
Current ratio0.9×+0.1×

Where this comes from

Reported directly by Cencora in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Cencora’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cencora's animal health — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cencora's animal health — revenue?
Cencora (COR) reported animal health — revenue of $1.44B in Q1 2026.
What does animal health — revenue mean?
This metric represents the total revenue generated from the sale of pharmaceutical products, medical supplies, and value-added services specifically for the animal health market. It encompasses the distribution of products to veterinary clinics, livestock producers, and other animal care providers. This segment serves as a key diversification pillar, distinct from human pharmaceutical distribution, by focusing on the specialized needs of the veterinary supply chain.